{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:31:12Z","timestamp":1788957072249,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009709","name":"Stichting De Weijerhorst","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009709","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.bone.2024.117066","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T12:00:14Z","timestamp":1709380814000},"page":"117066","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["PPI use is not associated with bone microarchitecture and strength assessed with HR-pQCT after three-years follow-up in patients visiting the Fracture Liaison Service"],"prefix":"10.1016","volume":"182","author":[{"given":"M.R.","family":"Schene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.A.M.","family":"Bevers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.J.F.","family":"van der Vijgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.H.M.","family":"Driessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Vranken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.Y.","family":"van der Velde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.C.","family":"Willems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.E.","family":"Wyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"van den Bergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2024.117066_bb0005","article-title":"Reduce unnecessary use of proton pump inhibitors","volume":"379","author":"Farrell","year":"2022","journal-title":"Bmj"},{"key":"10.1016\/j.bone.2024.117066_bb0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/1756283X12437358","article-title":"Overutilization of proton-pump inhibitors: what the clinician needs to know","volume":"5","author":"Heidelbaugh","year":"2012","journal-title":"Therap. Adv. Gastroenterol."},{"key":"10.1016\/j.bone.2024.117066_bb0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejim.2016.10.007","article-title":"The appropriate use of proton pump inhibitors (PPIs): need for a reappraisal","volume":"37","author":"Savarino","year":"2017","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.bone.2024.117066_bb0020","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1053\/j.gastro.2019.05.056","article-title":"Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin","volume":"157","author":"Moayyedi","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bone.2024.117066_bb0025","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/apt.13194","article-title":"Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies","volume":"41","author":"Attwood","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.bone.2024.117066_bb0030","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.dld.2016.05.018","article-title":"Are proton pump inhibitors really so dangerous?","volume":"48","author":"Savarino","year":"2016","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.bone.2024.117066_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810733","article-title":"Proton pump inhibitors and bone health: an update narrative review","volume":"23","author":"Lespessailles","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bone.2024.117066_bb0040","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/jgh.15879","article-title":"Long-term proton pump inhibitor use and risk of osteoporosis and hip fractures: a nationwide population-based and multicenter cohort study using a common data model","volume":"37","author":"Park","year":"2022","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bone.2024.117066_bb0045","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00198-015-3365-x","article-title":"Proton-pump inhibitors and risk of fractures: an update meta-analysis","volume":"27","author":"Zhou","year":"2016","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2024.117066_bb0050","doi-asserted-by":"crossref","first-page":"141","DOI":"10.11005\/jbm.2018.25.3.141","article-title":"Proton-pump inhibitor use and fracture risk: an updated systematic review and Meta-analysis","volume":"25","author":"Nassar","year":"2018","journal-title":"J. Bone Metab."},{"key":"10.1016\/j.bone.2024.117066_bb0055","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00198-018-4788-y","article-title":"Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies","volume":"30","author":"Poly","year":"2019","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2024.117066_bb0060","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1002\/jbmr.166","article-title":"Do proton pump inhibitors decrease calcium absorption?","volume":"25","author":"Hansen","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2024.117066_bb0065","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1002\/jbmr.108","article-title":"Inhibiting gastric acid production does not affect intestinal calcium absorption in young, healthy individuals: a randomized, crossover, controlled clinical trial","volume":"25","author":"Wright","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2024.117066_bb0070","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.amjmed.2005.02.007","article-title":"Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial","volume":"118","author":"O\u2019Connell","year":"2005","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bone.2024.117066_bb0075","doi-asserted-by":"crossref","DOI":"10.1007\/s00198-023-06867-8","article-title":"The association between proton pump inhibitors and hyperparathyroidism: a potential mechanism for increased fracture-results of a large observational cohort study","author":"Fitzpatrick","year":"2023","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2024.117066_bb0080","doi-asserted-by":"crossref","first-page":"8902367","DOI":"10.1155\/2021\/8902367","article-title":"Proton pump inhibitors and fractures in adults: a critical appraisal and review of the literature","volume":"2021","author":"Briganti","year":"2021","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.bone.2024.117066_bb0085","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1111\/febs.12478","article-title":"Dose-dependent inhibitory effects of proton pump inhibitors on human osteoclastic and osteoblastic cell activity","volume":"280","author":"Costa-Rodrigues","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.bone.2024.117066_bb0090","article-title":"Effect of proton pump inhibitors on bone mineral density: a systematic review and meta-analysis of observational studies","volume":"13","author":"Aleraij","year":"2020","journal-title":"Bone Rep."},{"key":"10.1016\/j.bone.2024.117066_bb0095","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jocd.2018.06.008","article-title":"Lower trabecular bone score is associated with the use of proton pump inhibitors","volume":"22","author":"Shin","year":"2019","journal-title":"J. Clin. Densitom."},{"key":"10.1016\/j.bone.2024.117066_bb0100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/PHAR.1007","article-title":"Fracture risk and bone mineral density reduction associated with proton pump inhibitors","volume":"32","author":"Lau","year":"2012","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bone.2024.117066_bb0105","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2174\/1573397111666151026222921","article-title":"Correlation of bone mineral density scores and proton pump inhibitors use in the elderly","volume":"12","author":"Amoako","year":"2016","journal-title":"Curr. Rheumatol. Rev."},{"key":"10.1016\/j.bone.2024.117066_bb0110","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bone.2013.09.014","article-title":"Use of proton pump inhibitors is associated with lower trabecular bone density in older individuals","volume":"57","author":"Maggio","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.bone.2024.117066_bb0115","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ajg.2016.481","article-title":"Long-term proton pump inhibitor use is not associated with changes in bone strength and structure","volume":"112","author":"Targownik","year":"2017","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.bone.2024.117066_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2022.116668","article-title":"Bone microstructure in proton pump inhibitor users","volume":"168","author":"Kondapalli","year":"2023","journal-title":"Bone"},{"key":"10.1016\/j.bone.2024.117066_bb0125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/ard.2008.092775","article-title":"Clinical subsequent fractures cluster in time after first fractures","volume":"68","author":"van Geel","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bone.2024.117066_bb0130","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-058983","article-title":"Association between incident falls and subsequent fractures in patients attending the fracture liaison service after an index fracture: a 3-year prospective observational cohort study","volume":"12","author":"Vranken","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.bone.2024.117066_bb0135","series-title":"Richtlijn Osteoporose en Fractuurpreventie, Derde Herziening [Dutch] Dutch Institute for Healthcare Improvement CBO","author":"Dutch Institute for Healthcare Improvement CBO","year":"2011"},{"key":"10.1016\/j.bone.2024.117066_bb0140","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(98)09075-8","article-title":"Mortality after all major types of osteoporotic fracture in men and women: an observational study","volume":"353","author":"Center","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2024.117066_bb0145","series-title":"ICD-10: international statistical classification of diseases and related health problems, Tenth revision","author":"World Health Organisation","year":"2004"},{"key":"10.1016\/j.bone.2024.117066_bb0150","series-title":"ATC\/DDD Index 2023","year":"2023"},{"key":"10.1016\/j.bone.2024.117066_bb0155","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jc.2010-2135","article-title":"Contributors to secondary osteoporosis and metabolic bone diseases in patients presenting with a clinical fracture","volume":"96","author":"Bours","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2024.117066_bb0160","first-page":"1","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"7","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group (2017)","year":"2011","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.bone.2024.117066_bb0165","series-title":"Physical Functioning in Patients with a Recent Fracture: The \u201cCan Do, Do Do\u201d Framework Applied to Explore Physical Capacity, Physical Activity and Fall Risk Factors. Calcif Tissue Int","author":"Schene","year":"2023"},{"key":"10.1016\/j.bone.2024.117066_bb0170","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"10.1016\/j.bone.2024.117066_bb0175","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jocd.2015.05.063","article-title":"Assessment of lean mass and physical performance in sarcopenia","volume":"18","author":"Cawthon","year":"2015","journal-title":"J. Clin. Densitom."},{"key":"10.1016\/j.bone.2024.117066_bb0180","series-title":"Prevention and Management of Osteoporosis. World Health Organization, World Health Organization Technical Report Series","author":"World Health Organisation","year":"2003"},{"key":"10.1016\/j.bone.2024.117066_bb0185","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","article-title":"Vertebral fracture assessment using a semiquantitative technique","volume":"8","author":"Genant","year":"1993","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2024.117066_bb0190","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bone.2011.10.003","article-title":"Visual grading of motion induced image degradation in high resolution peripheral computed tomography: impact of image quality on measures of bone density and micro-architecture","volume":"50","author":"Pialat","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.bone.2024.117066_bb0195","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00198-020-05438-5","article-title":"Guidelines for the assessment of bone density and microarchitecture in vivo using high-resolution peripheral quantitative computed tomography","volume":"31","author":"Whittier","year":"2020","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2024.117066_bb0200","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S8756-3282(02)00736-6","article-title":"Estimation of distal radius failure load with micro-finite element analysis models based on three-dimensional peripheral quantitative computed tomography images","volume":"30","author":"Pistoia","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.bone.2024.117066_bb0205","series-title":"Step Safely: Strategies for Preventing and Managing Falls across the Life-Course","author":"World Health Organization","year":"2021"},{"key":"10.1016\/j.bone.2024.117066_bb0210","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00198-021-05999-z","article-title":"The clinical application of high-resolution peripheral computed tomography (HR-pQCT) in adults: state of the art and future directions","volume":"32","author":"van den Bergh","year":"2021","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2024.117066_bb0215","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s00198-020-05449-2","article-title":"Longitu- dinal bone microarchitectural changes are best detected using image registration","volume":"31","author":"Kemp","year":"2020","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2024.117066_bb0220","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jocd.2020.10.001","article-title":"Precision of 3D registration analysis for longitudinal study of second-generation HR-pQCT","volume":"24","author":"Chiba","year":"2021","journal-title":"J. Clin. Densitom."},{"key":"10.1016\/j.bone.2024.117066_bb0225","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/jgs.12826","article-title":"Proton pump inhibitors and functional decline in older adults discharged from acute care hospitals","volume":"62","author":"Corsonello","year":"2014","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.bone.2024.117066_bb0230","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1002\/jbmr.2279","article-title":"Long-term proton pump inhibitor therapy and falls and fractures in elderly women: a prospective cohort study","volume":"29","author":"Lewis","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2024.117066_bb0235","first-page":"372.e371","article-title":"Fall-risk-increasing drugs: a systematic review and meta-analysis: III","volume":"19","author":"Seppala","year":"2018","journal-title":"Others. J Am Med Dir Assoc"},{"key":"10.1016\/j.bone.2024.117066_bb0240","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/qjmed\/hcy245","article-title":"Risk of fall in patients taking proton pump inhibitors: a meta-analysis","volume":"112","author":"Lapumnuaypol","year":"2019","journal-title":"Qjm"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328224000553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328224000553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:08:15Z","timestamp":1757614095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328224000553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":48,"alternative-id":["S8756328224000553"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2024.117066","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PPI use is not associated with bone microarchitecture and strength assessed with HR-pQCT after three-years follow-up in patients visiting the Fracture Liaison Service","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2024.117066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117066"}}